LON:RTW RTW Biotech Opportunities (RTW) Share Price, News & Analysis GBX 1.52 -0.02 (-1.30%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlines About RTW Biotech Opportunities Stock (LON:RTW) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get RTW alerts:Sign Up Key Stats Today's Range 1.51▼ 1.5350-Day Range 1.51▼ 1.5852-Week Range 1.05▼ 1.73Volume116,084 shsAverage Volume508,954 shsMarket Capitalization£5.10 millionP/E Ratio4.22Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.Read More… Banking failure dead ahead (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Receive RTW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RTW Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter. Email Address RTW Stock News HeadlinesBiotech industry booms in Eastern Carolina, promoting local job growthOctober 17, 2024 | msn.comRtw Biotech Regulatory NewsOctober 3, 2024 | lse.co.ukBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonOctober 31, 2024 | Porter & Company (Ad)Aktis Oncology raises $175m to advance radiopharmaceutical pipelineOctober 1, 2024 | msn.comAKTIS ONCOLOGY ANNOUNCES $175 MILLION OVERSUBSCRIBED SERIES B FINANCING TO FURTHER ADVANCE ITS PROPRIETARY RADIOPHARMACEUTICAL PIPELINESeptember 30, 2024 | finance.yahoo.comCan the billion-dollar bet on biotech finally reverse aging?September 30, 2024 | businessinsider.comRTW Biotech notes BioAge Labs' USD198 million initial public offeringSeptember 27, 2024 | lse.co.uk3 'Repeatable' Biotech TradesSeptember 25, 2024 | seekingalpha.comSee More Headlines RTW Stock Analysis - Frequently Asked Questions How have RTW shares performed this year? RTW Biotech Opportunities' stock was trading at GBX 1.40 at the beginning of the year. Since then, RTW stock has increased by 8.3% and is now trading at GBX 1.52. View the best growth stocks for 2024 here. How do I buy shares of RTW Biotech Opportunities? Shares of RTW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:RTW CUSIPN/A CIKN/A Webwww.rtwfunds.com Phone646-597-6980FaxN/AEmployees4,971Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.36 Trailing P/E Ratio4.22 Forward P/E RatioN/A P/E GrowthN/ANet Income£83.19 million Net Margins1,994.76% Pretax MarginN/A Return on Equity21.42% Return on Assets-0.47% Debt Debt-to-Equity RatioN/A Current Ratio6.35 Quick Ratio0.81 Sales & Book Value Annual Sales£4.17 million Price / Sales1.22 Cash FlowGBX 4.72 per share Price / Cash Flow0.32 Book ValueGBX 190 per share Price / Book0.01Miscellaneous Outstanding Shares335,710,000Free FloatN/AMarket Cap£5.10 million OptionableNot Optionable Beta0.60 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (LON:RTW) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
